The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Causes and Outcomes of the Acute Chest Syndrome in Sickle Cell Disease
Open accessAbstract
BACKGROUND: The acute chest syndrome is the leading cause of death among patients with sickle cell disease. Since its cause is largely unknown, therapy is supportive. Pilot studies with improved diagnostic techniques suggest that infection and fat embolism are underdiagnosed in patients with the syndrome. METHODS: In a 30-center study, we analyzed 671 episodes of the acute chest syndrome in 538 patients with sickle cell disease to determine the cause, outcome, and response to therapy. We evaluated a treatment protocol that included matched transfusions, bronchodilators, and bronchoscopy. Samples of blood and respiratory tract secretions were sent to central laboratories for antibody testing, culture, DNA testing, and histopathological analyses. RESULTS: Nearly half the patients were initially admitted for another reason, mainly pain. When the acute chest syndrome was diagnosed, patients had hypoxia, decreasing hemoglobin values, and progressive multilobar pneumonia. The mean length of hospitalization was 10.5 days. Thirteen percent of patients required mechanical ventilation, and 3 percent died. Patients who were 20 or more years of age had a more severe course than those who were younger. Neurologic events occurred in 11 percent of patients, among whom 46 percent had respiratory failure. Treatment with phenotypically matched transfusions improved oxygenation, with a 1 percent rate of alloimmunization. One fifth of the patients who were treated with bronchodilators had clinical improvement. Eighty-one percent of patients who required mechanical ventilation recovered. A specific cause of the acute chest syndrome was identified in 38 percent of all episodes and 70 percent of episodes with complete data. Among the specific causes were pulmonary fat embolism and 27 different infectious pathogens. Eighteen patients died, and the most common causes of death were pulmonary emboli and infectious bronchopneumonia. Infection was a contributing factor in 56 percent of the deaths. CONCLUSIONS: Among patients with sickle cell disease, the acute chest syndrome is commonly precipitated by fat embolism and infection, especially community-acquired pneumonia. Among older patients and those with neurologic symptoms, the syndrome often progresses to respiratory failure. Treatment with transfusions and bronchodilators improves oxygenation, and with aggressive treatment, most patients who have respiratory failure recover.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Epidemiologically, ACS is a complication of VOC, based on its typical development 2–3 days after the onset of vaso-occlusive pain (111)”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [111]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“it is more common in children and, if untreated, has a high mortality [9% in adults (111)].”
From Pathophysiology of Sickle Cell Disease (2019) · cites this paper as [111]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mortality in sickle cell disease. Life expectancy and risk factors for early death
Platt, O. S., Brambilla, D. J., Rosse, W. F., Milner, P. F., Castro, O., Steinberg, M. H., & Klug, P. P. (1994) · New England Journal of Medicine · doi:10.1056/nejm199406093302303 · Cited by 3,320
Rickinson, A. B. (2002) · PubMed · doi:10.1016/s0168-1702(01)00436-1 · Cited by 2,182
Cerebrovascular accidents in sickle cell disease: rates and risk factors.
(1998) · PubMed · doi:10.1182/blood.v91.1.288 · Cited by 1,694
Incidence of and Risk Factors for Ventilator-Associated Pneumonia in Critically Ill Patients
Cook, D. J., Walter, S. D., Cook, R. J., Griffith, L. E., Guyatt, G. H., Leasa, D., Jaeschke, R. Z., & Brun‐Buisson, C. (1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-129-6-199809150-00002 · Cited by 1,108
Castro, O. L., Brambilla, D. J., Thorington, B. D., Reindorf, C. A., Scott, R., GILLETTE, P. N., Vera, J., & Levy, P. S. (1994) · Blood · doi:10.1182/blood.v84.2.643.643 · Cited by 805
Vichinsky, E. P., Haberkern, C. M., Neumayr, L., Earles, A. N., Black, D. M., Koshy, M., Pegelow, C. H., Abboud, M. R., Ohene‐Frempong, K., & Iyer, R. V. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507273330402 · Cited by 644
Self-citationCastro, O. L., Brambilla, D. J., Thorington, B. D., et al. (1994) · Blood · doi:10.1182/blood.v84.2.643.bloodjournal842643 · Cited by 615
Acute Chest Syndrome in Sickle Cell Disease: Clinical Presentation and Course
Vichinsky, E. P., Styles, L. A., Colangelo, L. H., Wright, E. C., Castro, O., Nickerson, B., & Disease, T. C. S. O. S. C. (1997) · Blood · doi:10.1182/blood.v89.5.1787 · Cited by 573
Self-citationSickle cell chronic lung disease: prior morbidity and the risk of pulmonary failure.
Powars, D., WEIDMAN, J. A., Odom‐Maryon, T., Niland, J. C., & Johnson, C. M. (1988) · PubMed · Cited by 329
Sickle Cell Chronic Lung Disease
Powars, D. R., WEIDMAN, J. A., ODOM-MARYON, T., Niland, J. C., & Johnson, C. S. (1988) · Medicine · doi:10.1097/00005792-198801000-00005 · Cited by 283
Research works printed but not linked: 9
- Vichinsky E, 1991, Semin Hematol, 28, 220
- Sprinkle RH, 1986, Am J Pediatr Hematol Oncol, 8, 105
- Landry ML, Hsiung GD. Primary isolation of viruses. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:43-69.
- Waites KB, Taylor-Robinson D. Mycoplasma and Ureaplasma. In: Murray PR, ed. Manual of clinical microbiology. 7th ed. Washington, D.C.: ASM Press, 1999:782-806.
- Lennette ET, Lennette DA. Immune adherence hemagglutination. In: Specter S, Lancz G, eds. Clinical virology manual. 2nd ed. New York: Elsevier Science Publishing, 1992:251-61.
- Schachter J. Chlamydiae. In: Balows A, Hausler WJ Jr, Hermann KL, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, D.C.: ASM Press, 1991:1045-53.
- Ohene-Frempong K, 1998, Blood, 91, 288
- Mallouh AA, 1988, Am J Dis Child, 142, 178
- Ibe BO, 1997, Am J Physiol, 272, L597
Cited by
Sorted by citations
Items 101–200 of 1,000
Pulmonary manifestations of sickle cell disease
Siddiqui, A. K., & Ahmed, S. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.933.384 · Cited by 105
Darbari, D. S., Onyekwere, O. C., Nouraie, M. S., Minniti, C. P., Luchtman‐Jones, L., RANA, S. R., Sable, C., Ensing, G. J., Dham, N., Campbell, A., et al. (2011) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2011.07.018 · Cited by 105
Adesina, O., Brunson, A. M., Keegan, T. H. M., & Wun, T. (2017) · Blood Advances · doi:10.1182/bloodadvances.2017005256 · Cited by 103
Pulmonary embolism in sickle cell disease: a case–control study
Novelli, E. M., Huynh, C., Gladwin, M. T., Moore, C. G., & Ragni, M. V. (2012) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2012.04697.x · Cited by 102
Pulmonary Complications of Sickle Cell Anemia
Minter, K. R., & Gladwin, M. T. (2001) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.164.11.2104101 · Cited by 102
Burden of Influenza-Related Hospitalizations Among Children With Sickle Cell Disease
Bundy, D. G., Strouse, J. J., Casella, J. F., & Miller, M. R. (2010) · PEDIATRICS · doi:10.1542/peds.2009-1465 · Cited by 99
Sickle cell disease: Clinical presentation and management of a global health challenge
Houwing, M. E., de Pagter, P. J., van Beers, E. J., Biemond, B. J., Rettenbacher, E., Rijneveld, A. W., Schols, E. M., Philipsen, J. N. J., Tamminga, R. Y. J., van Draat, K. F., et al. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.05.004 · Cited by 106
Bone marrow embolism in sickle cell disease: A review
Dang, N. C., Johnson, C. S., Eslami‐Farsani, M., & Haywood, L. J. (2005) · American Journal of Hematology · doi:10.1002/ajh.20348 · Cited by 98
Asthma and acute chest in sickle‐cell disease
Boyd, J. H., Moinuddin, A., Strunk, R. C., & DeBaun, M. R. (2004) · Pediatric Pulmonology · doi:10.1002/ppul.20066 · Cited by 97
Quality-of-Care Indicators for Children With Sickle Cell Disease
Wang, C.-H. J., Kavanagh, P. L., Little, A. A., Holliman, J. B., & Sprinz, P. G. (2011) · PEDIATRICS · doi:10.1542/peds.2010-1791 · Cited by 97
Secretory phospholipase A2 predicts impending acute chest syndrome in sickle cell disease
Styles, L. A., Aarsman, A. J., Vichinsky, E. P., & Kuypers, F. A. (2000) · Blood · doi:10.1182/blood.v96.9.3276 · Cited by 105
Self-citationSickle‐cell disease and the heart: review of the current literature
Voskaridou, E., Christoulas, D., & Terpos, E. (2012) · British Journal of Haematology · doi:10.1111/j.1365-2141.2012.09143.x · Cited by 98
Vats, R., Brzóska, T., Bennewitz, M. F., Jimenez, M. A., Pradhan‐Sundd, T., Tütüncüoğlu, E., Jonassaint, J., Gutierrez, E., Watkins, S. C., Shiva, S., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201807-1370oc · Cited by 99
Systemic Exposure to Morphine and the Risk of Acute Chest Syndrome in Sickle Cell Disease
Kopecky, E. A., Jacobson, S., Joshi, P., & Koren, G. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.10.007 · Cited by 95
Henderson, J. N., Noetzel, M. J., McKinstry, R. C., White, D. A., Armstrong, M. M., & DeBaun, M. R. (2002) · Blood · doi:10.1182/blood-2002-04-1183 · Cited by 95
Pain management for sickle cell disease in children and adults
Dunlop, R., & Bennett, K. C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003350.pub2 · Cited by 95
RetractedRed blood cell alloimmunization in sickle cell disease: prevalence in 2010
Miller, S. T., Kim, H., Weiner, D. L., Wager, C. G., Gallagher, D. M., Styles, L. A., Dampier, C., & Roseff, S. D. (2012) · Transfusion · doi:10.1111/j.1537-2995.2012.03796.x · Cited by 94
Sickle Cell Disease in Children
Meier, E. R., & Miller, J. L. (2012) · Drugs · doi:10.2165/11632890-000000000-00000 · Cited by 97
Current issues in blood transfusion for sickle cell disease
Wahl, S. K., & Quirolo, K. C. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e328321882e · Cited by 91
An Evidence-Based Approach to the Treatment of Adults with Sickle Cell Disease
Lottenberg, R., & Hassell, K. L. (2005) · Hematology · doi:10.1182/asheducation-2005.1.58 · Cited by 91
Acute chest syndrome: sickle cell disease
Paul, R. N., Castro, O. L., Aggarwal, A., & Oneal, P. A. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01647.x · Cited by 91
Quinn, C. T., Lee, N. J., Shull, E. P., Ahmad, N., Rogers, Z. R., & Buchanan, G. R. (2007) · Blood · doi:10.1182/blood-2007-07-100719 · Cited by 90
Tebbi, C. K. (2022) · Hemato · doi:10.3390/hemato3020024 · Cited by 110
Pecker, L. H., & Lanzkron, S. (2021) · Annals of Internal Medicine · doi:10.7326/aitc202101190 · Cited by 100
How I treat acute chest syndrome in children with sickle cell disease
Miller, S. T. (2011) · Blood · doi:10.1182/blood-2010-11-261834 · Cited by 87
Hematopoietic stem cell transplantation for sickle cell disease
Kassim, A. A., & Sharma, D. (2017) · Hematology/Oncology and Stem Cell Therapy · doi:10.1016/j.hemonc.2017.05.008 · Cited by 86
Asthma management: Reinventing the wheel in sickle cell disease
Morris, C. R. (2009) · American Journal of Hematology · doi:10.1002/ajh.21359 · Cited by 87
Vasculopathy, inflammation, and blood flow in leg ulcers of patients with sickle cell anemia
Minniti, C. P., Delaney, K., Gorbach, A. M., Xu, D., Lee, C. R., Malik, N., Koroulakis, A. I., Antalek, M. D., Maivelett, J., Peters-Lawrence, M. H., et al. (2013) · American Journal of Hematology · doi:10.1002/ajh.23571 · Cited by 86
The intersection between asthma and acute chest syndrome in children with sickle-cell anaemia
DeBaun, M. R., & Strunk, R. C. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00145-8 · Cited by 82
Nur, E., Gaartman, A. E., Tuijn, C. F. J. V., Tang, M. W., & Biemond, B. J. (2020) · American Journal of Hematology · doi:10.1002/ajh.25821 · Cited by 85
Quinn, C. T., & Ahmad, N. (2005) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05738.x · Cited by 85
Total THA in Adult Osteonecrosis Related to Sickle Cell Disease
Hernigou, P., Zilber, S., Filippini, P., Mathieu, G., Poignard, A., & Galactéros, F. (2008) · Clinical Orthopaedics and Related Research · doi:10.1007/s11999-007-0069-3 · Cited by 85
Orthopaedic Manifestations of Sickle Cell Disease
Vanderhave, K. L., Perkins, C. A., Scannell, B. P., & Brighton, B. K. (2018) · Journal of the American Academy of Orthopaedic Surgeons · doi:10.5435/jaaos-d-16-00255 · Cited by 84
Epidemiology of Stroke in Sickle Cell Disease
Kirkham, F. J., & Lagunju, I. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10184232 · Cited by 84
Nordness, M. E., Lynn, J., Zacharisen, M. C., Scott, P. J., & Kelly, K. J. (2005) · Clinical and Molecular Allergy · doi:10.1186/1476-7961-3-2 · Cited by 84
Bonds, D. R. (2004) · Blood Reviews · doi:10.1016/j.blre.2004.04.002 · Cited by 84
Epidemiologia de internações por doença falciforme no Brasil
Loureiro, M. M., & Rozenfeld, S. (2005) · Revista de Saúde Pública · doi:10.1590/s0034-89102005000600012 · Cited by 84
Cardiac iron overload in sickle‐cell disease
Meloni, A., Puliyel, M. M., Pepe, A., Berdoukas, V., Coates, T. D., & Wood, J. C. (2014) · American Journal of Hematology · doi:10.1002/ajh.23721 · Cited by 83
Severe pandemic H1N1 and seasonal influenza in children and young adults with sickle cell disease
Strouse, J. J., Reller, M. E., Bundy, D. G., Amoako, M. O., Cancio, M., Han, R. N., Valsamakis, A., & Casella, J. F. (2010) · Blood · doi:10.1182/blood-2010-05-282194 · Cited by 83
Bean, C. J., Boulet, S. L., Ellingsen, D., Pyle, M., Barron‐Casella, E. A., Casella, J. F., Payne, A. B., Driggers, J., Trau, H. A., Yang, G., et al. (2012) · Blood · doi:10.1182/blood-2011-06-361642 · Cited by 83
Management of sickle cell disease in the community
Brousse, V. A. M., Makani, J., & Rees, D. C. (2014) · BMJ · doi:10.1136/bmj.g1765 · Cited by 82
Fisiopatologia das doenças falciformes: da mutação genética à insuficiência de múltiplos órgãos
Zago, M. A., & Pinto, A. C. S. (2007) · Revista Brasileira de Hematologia e Hemoterapia · doi:10.1590/s1516-84842007000300003 · Cited by 82
Mycoplasma Disease and Acute Chest Syndrome in Sickle Cell Disease
Neumayr, L., Lennette, E. T., Kelly, D. M., Earles, A. N., Embury, S. H., Groncy, P. K., Grossi, M., Grover, R., McMahon, L. C., Swerdlow, P. S., et al. (2003) · PEDIATRICS · doi:10.1542/peds.112.1.87 · Cited by 81
Self-citationRoseff, S. D. (2009) · Immunohematology · doi:10.21307/immunohematology-2019-234 · Cited by 79
Transfusion prevents acute chest syndrome predicted by elevated secretory phospholipase A2
Styles, L. A., Abboud, M. R., Larkin, S. K., Lo, M. C., & Kuypers, F. A. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2006.06409.x · Cited by 79
Self-citationIron Overload in Sickle Cell Disease
Raghupathy, R., Manwani, D. G., & Little, J. A. (2010) · Advances in Hematology · doi:10.1155/2010/272940 · Cited by 84
Vervloet, L. A., Marguet, C., & Camargos, P. A. M. (2007) · The Brazilian Journal of Infectious Diseases · doi:10.1590/s1413-86702007000500012 · Cited by 80
Sobota, A. E., Graham, D. A., Heeney, M. M., & Neufeld, E. J. (2009) · American Journal of Hematology · doi:10.1002/ajh.21565 · Cited by 78
Leifert, J. A. (2008) · International Journal of Laboratory Hematology · doi:10.1111/j.1751-553x.2008.01067.x · Cited by 78
Danielson, C. (2002) · Therapeutic Apheresis and Dialysis · doi:10.1046/j.1526-0968.2002.00396.x · Cited by 75
Principles and problems of transfusion in sickle cell disease
Telen, M. J. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90025-3 · Cited by 77
Buchanan, I. D., Woodward, M., & Reed, G. W. (2005) · Pediatric Blood & Cancer · doi:10.1002/pbc.20403 · Cited by 75
Ballas, S. K., Bauserman, R. L., McCarthy, W. F., Castro, O. L., Smith, W. R., & Waclawiw, M. A. (2010) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2010.03.020 · Cited by 74
Self-citationTransfusion Management in Sickle Cell Disease
Wanko, S. O., & Telen, M. J. (2005) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2005.07.002 · Cited by 73
Stroke in children with sickle cell disease
Kirkham, F. J., & DeBaun, M. R. (2004) · Current Treatment Options in Neurology · doi:10.1007/s11940-996-0028-4 · Cited by 72
Acute Pneumonia and Its Complications
Mani, C. S. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00034-7 · Cited by 72
CE: Understanding the Complications of Sickle Cell Disease
Tanabe, P. J., Spratling, R. G., Smith, D., Grissom, P. H., & Hulihan, M. (2019) · AJN American Journal of Nursing · doi:10.1097/01.naj.0000559779.40570.2c · Cited by 72
Howell, C., Douglas, K., Cho, G., El‐Ghariani, K., Taylor, P. C., Potok, D., Rintala, T., & Watkins, S. (2015) · Transfusion Medicine · doi:10.1111/tme.12205 · Cited by 72
Clinical biomarkers in sickle cell disease
Damanhouri, G. A., Jarullah, J. S., Marouf, S., Hindawi, S., Mushtaq, G., & Kamal, M. A. (2014) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.09.005 · Cited by 72
Anaesthesia for peculiar cells'a century of sickle cell disease
Firth, P. G. (2005) · British Journal of Anaesthesia · doi:10.1093/bja/aei129 · Cited by 72
Plastic Bronchitis and the Role of Bronchoscopy in the Acute Chest Syndrome of Sickle Cell Disease
Moser, C., Nussbaum, E. Z., & Cooper, D. M. (2001) · CHEST Journal · doi:10.1378/chest.120.2.608 · Cited by 72
AAAPT Diagnostic Criteria for Acute Sickle Cell Disease Pain
Field, J. J., Ballas, S. K., Campbell, C. M., Crosby, L. E., Dampier, C., Darbari, D. S., McClish, D. K., Smith, W. R., & Zempsky, W. T. (2018) · Journal of Pain · doi:10.1016/j.jpain.2018.12.003 · Cited by 73
Self-citationCOVID ‐19 pneumonia as a cause of acute chest syndrome in an adult sickle cell patient
Beerkens, F., John, M. M., Puliafito, B. R., Corbett, V., Edwards, C., & Tremblay, D. A. (2020) · American Journal of Hematology · doi:10.1002/ajh.25809 · Cited by 70
Knight-Madden, J. M., Forrester, T. S., Lewis, N. A., & Greenough, A. (2010) · Lung · doi:10.1007/s00408-010-9255-2 · Cited by 69
Assessment of Sickle Cell Pain in Children and Young Adults Using the Adolescent Pediatric Pain Tool
Franck, L. S., Treadwell, M. J., Jacob, E., & Vichinsky, E. P. (2002) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(01)00407-9 · Cited by 69
Self-citationPain Syndromes in Sickle Cell Disease: An Update
Niscola, P., Sorrentino, F., Scaramucci, L., de Fabritiis, P., & Cianciulli, P. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00601.x · Cited by 69
Pulmonary Complications of Hemoglobinopathies
Vij, R., & Machado, R. F. (2010) · CHEST Journal · doi:10.1378/chest.10-0317 · Cited by 70
Drašar, E., Igbineweka, N. E., Vasavda, N., Free, M., Awogbade, M., Allman, M., Mijović, A., & Thein, S. L. (2011) · British Journal of Haematology · doi:10.1111/j.1365-2141.2010.08451.x · Cited by 68
Chlamydia pneumoniae and Acute Chest Syndrome in Patients With Sickle Cell Disease
Dean, D., Neumayr, L., Kelly, D. M., Ballas, S. K., Kleman, K. M., Robertson, S., Iyer, R. V., Ware, R. E., Koshy, M., RACKOFF, W. R., et al. (2003) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-200301000-00010 · Cited by 67
Self-citationAcute chest syndrome of sickle cell disease: new light on an old problem
Stuart, M. J., & Setty, Y. B. N. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200103000-00009 · Cited by 67
Vats, R., Kaminski, T. W., Brzóska, T., Leech, J. A., Tütüncüoğlu, E., Katoch, O., Jonassaint, J., Tejero, J., Novelli, E. M., Pradhan‐Sundd, T., et al. (2022) · Blood · doi:10.1182/blood.2021014552 · Cited by 65
Cohen, R. T., Madadi, A. R., Blinder, M. A., DeBaun, M. R., Strunk, R. C., & Field, J. J. (2011) · American Journal of Hematology · doi:10.1002/ajh.22098 · Cited by 66
Thinking beyond sickling to better understand pain in sickle cell disease
Darbari, D. S., Ballas, S. K., & Clauw, D. J. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12340 · Cited by 65
Self-citationSickle cell disease in the older adult
Thein, M. S., Igbineweka, N. E., & Thein, S. L. (2016) · Pathology · doi:10.1016/j.pathol.2016.10.002 · Cited by 71
Ballas, S. K., Bauserman, R. L., McCarthy, W. F., Castro, O. L., Smith, W. R., & Waclawiw, M. A. (2010) · American Journal of Hematology · doi:10.1002/ajh.21750 · Cited by 64
Self-citationVascular Instability and Neurological Morbidity in Sickle Cell Disease: An Integrative Framework
Stotesbury, H., Kawadler, J. M., Hales, P. W., Saunders, D. E., Clark, C. A., & Kirkham, F. J. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00871 · Cited by 66
Wales, P. W., Carver, E. D., Crawford, M. W., & Kim, P. C. W. (2001) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2001.22944 · Cited by 64
Sickle Cell Disease—Pathophysiology and Treatment
Redding‐Lallinger, R., & Knoll, C. M. (2006) · Current problems in pediatric and adolescent health care · doi:10.1016/j.cppeds.2006.07.002 · Cited by 63
Upper Airway Lymphoid Tissue Size in Children With Sickle Cell Disease
Strauss, T., Sin, S., Marcus, C. L., Mason, T. B. A., McDonough, J. M., Allen, J. L., Caboot, J. B., Bowdre, C. Y., Jawad, A. F., Smith‐Whitley, K., et al. (2012) · CHEST Journal · doi:10.1378/chest.11-2013 · Cited by 63
Longitudinal assessment of lung function in children with sickle cell disease
Lunt, A. C., McGhee, E., Sylvester, K. P., Rafferty, G. F., Dick, M. C., Rees, D. C., Height, S. E., Thein, S. L., & Greenough, A. (2015) · Pediatric Pulmonology · doi:10.1002/ppul.23367 · Cited by 63
Pneumonia due to Chlamydia pneumoniae in children: Epidemiology, diagnosis, and treatment
Hammerschlag, M. R. (2003) · Pediatric Pulmonology · doi:10.1002/ppul.10326 · Cited by 63
Management of Children With Sickle Cell Disease: A Comprehensive Review of the Literature
Kavanagh, P. L., Sprinz, P. G., Vinci, S. R., Bauchner, H., & Wang, C.-H. J. (2011) · PEDIATRICS · doi:10.1542/peds.2010-3686 · Cited by 62
Chronic Pulmonary Complications of Sickle Cell Disease
Mehari, A., & Klings, E. S. (2016) · CHEST Journal · doi:10.1016/j.chest.2015.11.016 · Cited by 62
Bartolucci, P., Habibi, A., Khellaf, M., Roudot‐Thoraval, F., Melica, G., Lascaux, A., Moutereau, S., Loric, S., Wagner‐Ballon, O., Berkenou, J., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.038 · Cited by 62
Liem, R. I., O’Gorman, M. R. G., & Brown, D. (2004) · American Journal of Hematology · doi:10.1002/ajh.20054 · Cited by 61
Blood transfusions for treating acute chest syndrome in people with sickle cell disease
Dastgiri, S., & Dolatkhah, R. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007843.pub3 · Cited by 61
The lung in sickle cell disease
Knight, J., Murphy, T. M., & Browning, I. (1999) · Pediatric Pulmonology · doi:10.1002/(sici)1099-0496(199909)28:3 · Cited by 62
Hb‐based oxygen carriers: are we there yet?
Reid, T. J. A. (2003) · Transfusion · doi:10.1046/j.1537-2995.2003.00314.x · Cited by 61
Enhanced Pulmonary and Systemic Response to Endotoxin in Transgenic Sickle Mice
Holtzclaw, J. D., Jack, D. L., Aguayo, S. M., Eckman, J. R., Roman, J., & Hsu, L. L.-Y. (2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200302-224oc · Cited by 62
Chaturvedi, S., Ghafuri, D. L., Glassberg, J., Kassim, A. A., Rodeghier, M., & DeBaun, M. R. (2016) · American Journal of Hematology · doi:10.1002/ajh.24539 · Cited by 60
Indications for transfusion in the management of sickle cell disease
Han, H., Hensch, L., & Tubman, V. N. (2021) · Hematology · doi:10.1182/hematology.2021000307 · Cited by 60
Delayed Hemolytic Transfusion Reaction in Sickle Cell Disease
Scheunemann, L. P., & Ataga, K. I. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181c70e14 · Cited by 60
Anaesthetic management of the child with sickle cell disease
Marchant, W. A., & WALKER, I. A. (2003) · Pediatric Anesthesia · doi:10.1046/j.1460-9592.2003.01026.x · Cited by 60
Clinical differences between children and adults with pulmonary hypertension and sickle cell disease
Hagar, R. W., Michlitsch, J., Gardner, J. L., Vichinsky, E. P., & Morris, C. R. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06822.x · Cited by 60
Self-citationTherapy Insight: stroke risk and its management in patients with sickle cell disease
Kirkham, F. J. (2007) · Nature Clinical Practice Neurology · doi:10.1038/ncpneuro0495 · Cited by 60
Pediatric sickle cell disease: past successes and future challenges
Meier, E. R., & Rampersad, A. G. (2016) · Pediatric Research · doi:10.1038/pr.2016.204 · Cited by 59
Utilization of TCD screening for primary stroke prevention in children with sickle cell disease
Armstrong, J., Grimes, B. A., Sidney, S., Kronish, D., SHIBOSKI, S. C., Adams, R. J., & Fullerton, H. J. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a110da · Cited by 59
Management of sickle cell disease
de Montalembert, M. (2008) · BMJ · doi:10.1136/bmj.a1397 · Cited by 59
Sickle Cell Anemia: An Underappreciated and Unaddressed Contributor to Global Childhood Mortality
McGann, P. T. (2014) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2014.01.070 · Cited by 60
Driscoll, M. C. (2007) · Pediatrics in Review · doi:10.1542/pir.28-7-259 · Cited by 59
Metadata
- Authors
- Vichinsky, E. P., Neumayr, L. D., Earles, A. N., Williams, R., Lennette, E. T., Dean, D., Nickerson, B., Orringer, E., McKie, V., Bellevue, R., Daeschner, C., Abboud, M., Moncino, M., Ballas, S., Ware, R., & Manci, E. A.
- Affiliations
- University of California, San Francisco (US)
- Children's Hospital of Orange County (US)
- University of North Carolina at Chapel Hill (US)
- Augusta University (US)
- NewYork–Presbyterian Brooklyn Methodist Hospital (US)
- East Carolina University (US)
- Duke Medical Center (US)
- University of South Alabama Medical Center (US)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2000-06-22
- Volume
- 342
- Issue
- 25
- Pages
- 1855-1865
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2332642667
- Cited by
- 1,234
- References
- 44
- Citations by year
- 2026: 35 · 2025: 55 · 2024: 52 · 2023: 62 · 2022: 59 · 2021: 67 · 2020: 75 · 2019: 44 · 2018: 48 · 2017: 38 · 2016: 63 · 2015: 51 · 2014: 57 · 2013: 59 · 2012: 51
- FWCI
- 16.73
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Carolina Digital Repository (University of North Carolina at Chapel Hill) (submittedVersion)
- UNC Libraries
- Funders
- University of Southern California
- University of Miami
- Emory University
- University of South Alabama
- National Institutes of Health (5p60hl020985-25)
- National Heart, Lung, and Blood Institute (HL20985, HL 99016)
- National Center for Research Resources (M01 RR 01271)
- Children's Hospital of Pittsburgh
- Topics
- Health Sciences › Medicine › Genetics (clinical) › Hemoglobinopathies and Related Disorders
- Health Sciences › Medicine › Hematology › Blood transfusion and management
- Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections
- Keywords
- acute chest syndrome, sickle cell disease, pulmonary fat embolism, infection, community-acquired pneumonia, bronchodilators, bronchoscopy, mechanical ventilation, respiratory failure, neurological complications, mortality, hypoxia
- MeSH terms
- Acute Disease, Adolescent, Adult, Anemia, Sickle Cell, Blood Transfusion, Bronchodilator Agents, Chest Pain, Child, Child, Preschool, Embolism, Fat, Female, Humans, Infections, Lung Diseases, Male, Prospective Studies, Pulmonary Embolism, Respiration, Artificial, Respiratory Insufficiency, Proportional Hazards Models, Community-Acquired Infections
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
